Abstract
The most important issue of modern pharmacotherapy is not only efficacy, but also the safety of medicines. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is one of the main methods of treating acute and chronic pain in a wide range of diseases and pathological conditions. However, the prescription of this group of drugs requires consideration of the potential risks of complications, including from the side of the cardiovascular system. The purpose of the review was to assess the adverse reactions of the cardiovascular system when taking NSAIDs and approaches to their reduction. The article presents data on the mutual potential impact of cardiovascular diseases and musculoskeletal system, presents the results of large-scale studies of Russian and foreign authors and meta-analyzes of the NSAIDs effect on blood pressure profile, development of myocardial infarction, stroke and heart failure. The possible pathogenetic mechanisms of the side effects of NSAIDs are reviewed; the complexity of managing comorbid patients is demonstrated; it is shown that symptomatic treatment of pain and inflammatory syndrome should be carried out considering a personalized approach to the patient and rational choice of drugs.Before the NSAIDs prescription, it is necessary to consider all cardiovascular risk factors with the determination of the total risk of cardiovascular complications. In patients with a very high cardiovascular risk, the use of any NSAIDs should be avoided; with high and moderate risk, the use of NSAIDs with the most favorable cardiovascular safety profile is possible. If the patient belongs to the category of low total coronary risk, the doctor can choose any NSAIDs.
Highlights
Важнейшим вопросом современной фармакотерапии является не только эффективность, но и безопасность лекарственных средств
The purpose of the review was to assess the adverse reactions of the cardiovascular system when taking nonsteroidal anti-inflammatory drugs (NSAIDs) and approaches to their reduction
The article presents data on the mutual potential impact of cardiovascular diseases and musculoskeletal system, presents the results of large-scale studies of Russian and foreign authors and meta-analyzes of the NSAIDs effect on blood pressure profile, development of myocardial infarction, stroke and heart failure
Summary
Нежелательные реакции со стороны сердечно-сосудистой системы при приеме нестероидных противовоспалительных препаратов, и пути их снижения. Однако назначение этой группы препаратов требует учета потенциальных рисков развития осложнений, в том числе, со стороны сердечно-сосудистой системы (ССС). Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them Natalia V. If the patient belongs to the category of low total coronary risk, the doctor can choose any NSAIDs. For citation: Pyrikova N.V., Antropova O.N., Osipova I.V. Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them. Ограничивающим использование НПВП, можно назвать нежелательные явления (НЯ), в том числе, со стороны сердечно-сосудистой системы (ССС). При этом исходное поражение кардиоваскулярной системы, без сомнения – основной ФР класс-специфических НЯ, вызванных НПВП [7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
